title: [Late sequelae and cosmetic outcome after radiotherapy in breast conserving therapy].
abstract: Radiotherapy after breast-conserving therapy for early breast cancer is reported to adversely affect the cosmetic outcome. The incidence of radiation-induced fibroatrophy is around 10% at 5 years. A better knowledge of its pathophysiology has revealed the essential role of activated fibroblasts and reactive oxygen species, mediated by TGF beta 1, allowing the development of antioxidant in the management of the established radiation-induced fibroatrophy. Cosmetic sequelae are evaluated with standardized scales, such as the LENT-SOMA and must be monitored during at least 5 years. The main factors determining the occurrence of sequelae are a large breast volume, dose heterogeneity and the use of tumour bed boost after whole-breast radiation therapy. Intensity modulated radiotherapy and partial breast irradiation position themselves as a good alternatives to reduce the incidence of late skin side effects. The use of predictive tests of intrinsic radiosensitivity might fit into the therapeutic strategy.
authors.affiliation: Service de radiothérapie, institut de cancérologie de l'Ouest René-Gauducheau, Saint-Herblain, France. meladore@gmail.com
authors.forename: M
authors.initials: M
authors.lastname: Doré
authors.forename: C
authors.initials: C
authors.lastname: Hennequin
mesh_terms: D001284:Atrophy / Q000209:etiology; D001940:Breast / Q000473:pathology; D001943:Breast Neoplasms / Q000532:radiotherapy* / Q000601:surgery*; D055088:Early Detection of Cancer; D004954:Esthetics; D005260:Female; D005355:Fibrosis / Q000209:etiology; D006801:Humans; D015412:Mastectomy, Segmental; D058628:Myofibroblasts / Q000473:pathology; D011788:Quality of Life; D011832:Radiation Injuries / Q000517:prevention & control; D011836:Radiation Tolerance; D011878:Radiotherapy / Q000009:adverse effects; D012307:Risk Factors; D053773:Transforming Growth Factor beta1 / Q000502:physiology
chemical_list: D053773:Transforming Growth Factor beta1